Sallee, Verney L.

Patent Applications and Registrations

Patent applications and USPTO patent grants for Sallee, Verney L..The latest application filed is for "use of cloprostenol and fluprostenol analogues to treat glaucoma and ocular hypertension".

Company Profile

0.13.4

Sallee, Verney L. - Burleson TX
Sallee, Verney L. - Los Alamos NM
Sallee; Verney L. - Southlake TX

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Use of cloprostenol and fluprostenol analogues to treat glaucoma and ocular hypertension App 20040198817 - Klimko, Peter G. ; et al.	2004-10-07
Use of cloprostenol and fluprostenol analogues to treat glaucoma and ocular hypertension Grant 6,723,748 - Klimko , et al. April 20, 2	2004-04-20
R-reliprodil for treating glaucoma App 20030212107 - Kapin, Michael A. ; et al.	2003-11-13
Use of cloprostenol and fluprostenol analogues to treat glaucoma and ocular hypertension App 20020111381 - Dean, Thomas R. ; et al.	2002-08-15
11-halo prostaglandins for the treatment of glaucoma or ocular hypertension Grant 6,353,000 - Sallee , et al. March 5, 2	2002-03-05
Use of cloprostenol and fluprostenol analogues to treat glaucoma and ocular hypertension App 20010023258 - Dean, Thomas R. ; et al.	2001-09-20
Use of cloprostenol and fluprostenol analogues to treat glaucoma and ocular hypertension Grant 6,184,250 - Klimko , et al. February 6, 2	2001-02-06
Combinations of DP and FP type prostaglandins for lowering IOP Grant 6,166,073 - Dean , et al. December 26, 2	2000-12-26
substituted tetrahydrofuran analogs of prostaglandins as ocular hypotensives Grant 6,025,392 - Selliah , et al. February 15, 2	2000-02-15
Use of cloprostenol and fluprostenol analogues to treat glaucoma and ocular hypertension Grant 5,889,052 - Klimko , et al. March 30, 1	1999-03-30
Combinations of prostaglandins and clonidine derivatives for the treatment of glaucoma Grant 5,811,443 - DeSantis, Jr. , et al. September 22, 1	1998-09-22
Use of certain 9-haloprostaglandins to treat glaucoma and ocular hypertension Grant 5,627,209 - DeSantis, Jr. , et al. May 6, 1	1997-05-06
Use of cloprostenol, fluprostenol and their salts and esters to treat glaucoma and ocular hypertension Grant 5,510,383 - Bishop , et al. April 23, 1	1996-04-23
Combinations of prostaglandins and clonidine derivatives for the treatment of glaucoma Grant 5,480,900 - DeSantis, Jr. , et al. January 2, 1	1996-01-02
Prostaglandin combinations in glaucoma therapy Grant 5,173,507 - DeSantis , et al. December 22, 1	1992-12-22
Use of trimoprostil and derivatives in glaucoma therapy Grant 4,822,819 - DeSantis , et al. April 18, 1	1989-04-18
Use of tri-methyl PG-F.sub.2 a and derivatives in glaucoma therapy Grant 4,822,820 - DeSantis , et al. April 18, 1	1989-04-18

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.